Ethical considerations and challenges in first-in-human research.

Area of Science:

• Biomedical Ethics
• Clinical Research Ethics

Background:

• First-in-human (FIH) research is critical for translating novel therapies from laboratory to clinical application.
• Ethical considerations are paramount due to inherent uncertainties in risk-benefit assessments and potential for severe adverse events.
• Emerging therapies like gene transfer and stem cell treatments present new ethical challenges.

Purpose of the Study:

• To present and discuss ethical considerations and challenges in FIH research.
• To review ethical principles and their application to specific ethical issues in FIH trials.
• To propose solutions for addressing identified ethical challenges in FIH research.

Main Methods:

• Literature review of ethical principles and their application to FIH research.
• Analysis of ethical issues with illustrative examples.
• Discussion of potential solutions for ethical challenges.

Main Results:

• Identified four major ethical issues in FIH research: risk-benefit assessment, target population selection, informed consent, and conflict of interest.
• Provided a framework for applying ethical principles to these issues.
• Suggested practical solutions for mitigating ethical challenges.

Conclusions:

• Ethical oversight is crucial for responsible FIH research, especially with novel therapies.
• Addressing risk-benefit justification, participant selection, informed consent, and conflicts of interest is essential.
• Proactive ethical analysis and mitigation strategies support the safe advancement of innovative treatments.